Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of ...

The biochip market size is calculated at USD 14.37 billion in 2025 and is expected to reach around USD 42.15 billion by 2034, ...

Q4 2025 Earnings Call Transcript November 14, 2025 Twist Bioscience Corporation beats earnings expectations. Reported EPS is ...

The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

Researchers at Dartmouth–Hitchcock Medical Center investigated whether OGM could detect harmful chromosomal changes in patients with a family history or risk of recurrent pregnancy loss who had ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on ...

Adverse drug reactions are the fourth-leading cause of death in the United States 1. In addition, many patients are refractory to drug treatment or receive limited benefit from such therapy. DNA ...

Microarray testing can only be performed on an amniocentesis or CVS. These tests are more advanced than NIPT and are capable of looking at chromosomes to find out if any of them are missing a small ...

With rapid advancements in whole genome sequencing, Kadam noted that genetic science is moving toward even more comprehensive ...